GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Biomark Diagnostics Inc (OTCPK:BMKDF) » Definitions » Days Sales Outstanding

Biomark Diagnostics (Biomark Diagnostics) Days Sales Outstanding : 83.89 (As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Biomark Diagnostics Days Sales Outstanding?

Biomark Diagnostics's average Accounts Receivable for the three months ended in Dec. 2023 was $0.03 Mil. Biomark Diagnostics's Revenue for the three months ended in Dec. 2023 was $0.03 Mil. Hence, Biomark Diagnostics's Days Sales Outstanding for the three months ended in Dec. 2023 was 83.89.

The historical rank and industry rank for Biomark Diagnostics's Days Sales Outstanding or its related term are showing as below:

BMKDF' s Days Sales Outstanding Range Over the Past 10 Years
Min: 20.12   Med: 138.37   Max: 452.1
Current: 69.88

During the past 10 years, Biomark Diagnostics's highest Days Sales Outstanding was 452.10. The lowest was 20.12. And the median was 138.37.

BMKDF's Days Sales Outstanding is ranked worse than
50.67% of 223 companies
in the Medical Diagnostics & Research industry
Industry Median: 69.51 vs BMKDF: 69.88

Biomark Diagnostics's Days Sales Outstanding increased from Dec. 2022 (64.21) to Dec. 2023 (83.89).


Biomark Diagnostics Days Sales Outstanding Historical Data

The historical data trend for Biomark Diagnostics's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomark Diagnostics Days Sales Outstanding Chart

Biomark Diagnostics Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 20.39 - 448.43 146.65

Biomark Diagnostics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 64.21 64.50 65.40 58.87 83.89

Competitive Comparison of Biomark Diagnostics's Days Sales Outstanding

For the Diagnostics & Research subindustry, Biomark Diagnostics's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biomark Diagnostics's Days Sales Outstanding Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Biomark Diagnostics's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Biomark Diagnostics's Days Sales Outstanding falls into.



Biomark Diagnostics Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Biomark Diagnostics's Days Sales Outstanding for the fiscal year that ended in Mar. 2023 is calculated as

Days Sales Outstanding (A: Mar. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Mar. 2022 ) + Accounts Receivable (A: Mar. 2023 )) / count ) / Revenue (A: Mar. 2023 )*Days in Period
=( (0.065 + 0.025) / 2 ) / 0.112*365
=0.045 / 0.112*365
=146.65

Biomark Diagnostics's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding (Q: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Sep. 2023 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (0.022 + 0.035) / 2 ) / 0.031*365 / 4
=0.0285 / 0.031*365 / 4
=83.89

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biomark Diagnostics  (OTCPK:BMKDF) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Biomark Diagnostics Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Biomark Diagnostics's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Biomark Diagnostics (Biomark Diagnostics) Business Description

Traded in Other Exchanges
Address
130 - 3851 Shell Road, Richmond, BC, CAN, V6X 2W2
Biomark Diagnostics Inc is a Canada-based oncology-focused company. It is engaged in the development of the early-stage cancer diagnostic technology platform. The company develops non-invasive cancer diagnostic solutions which will help to detect, monitor, and assess early treatment for cancer. Its research and development are focused on the role that metabolomics plays in early cancer detection. It is currently focused on bringing its liquid biopsy-based cancer diagnostic tests and detection solution to commercialization.

Biomark Diagnostics (Biomark Diagnostics) Headlines

No Headlines